These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 7944342)

  • 1. Immune recognition, antigen design, and catalytic antibody production.
    Tramontano A
    Appl Biochem Biotechnol; 1994; 47(2-3):257-73; discussion 273-5. PubMed ID: 7944342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hapten design for the generation of catalytic antibodies.
    Thomas NR
    Appl Biochem Biotechnol; 1994; 47(2-3):345-72. PubMed ID: 7944348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmenting the efficacy of anti-cocaine catalytic antibodies through chimeric hapten design and combinatorial vaccination.
    Wenthur CJ; Cai X; Ellis BA; Janda KD
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3666-3668. PubMed ID: 28709828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of flexible and constrained haptens in eliciting antibody catalysts for paraoxon hydrolysis.
    Spivak DA; Hoffman TZ; Moore AH; Taylor MJ; Janda KD
    Bioorg Med Chem; 1999 Jun; 7(6):1145-50. PubMed ID: 10428386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploiting antibodies as catalysts: potential therapeutic applications.
    Tellier C
    Transfus Clin Biol; 2002 Jan; 9(1):1-8. PubMed ID: 11889895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural insights into the evolution of an antibody combining site.
    Wedemayer GJ; Patten PA; Wang LH; Schultz PG; Stevens RC
    Science; 1997 Jun; 276(5319):1665-9. PubMed ID: 9180069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catalytic antibodies: hapten design strategies and screening methods.
    Xu Y; Yamamoto N; Janda KD
    Bioorg Med Chem; 2004 Oct; 12(20):5247-68. PubMed ID: 15388154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The scope of antibody catalysis.
    Jacobsen JR; Schultz PG
    Curr Opin Struct Biol; 1995 Dec; 5(6):818-24. PubMed ID: 8749371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Directed evolution governed by controlling the molecular recognition between an abzyme and its haptenic transition-state analog.
    Takahashi-Ando N; Kakinuma H; Fujii I; Nishi Y
    J Immunol Methods; 2004 Nov; 294(1-2):1-14. PubMed ID: 15604011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A structural basis for transition-state stabilization in antibody-catalyzed hydrolysis: crystal structures of an abzyme at 1. 8 A resolution.
    Kristensen O; Vassylyev DG; Tanaka F; Morikawa K; Fujii I
    J Mol Biol; 1998 Aug; 281(3):501-11. PubMed ID: 9698565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunological evolution of catalysis.
    Patten PA; Gray NS; Yang PL; Marks CB; Wedemayer GJ; Boniface JJ; Stevens RC; Schultz PG
    Science; 1996 Feb; 271(5252):1086-91. PubMed ID: 8599084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward bifunctional antibody catalysis.
    Kikuchi K; Hannak RB; Guo MJ; Kirby AJ; Hilvert D
    Bioorg Med Chem; 2006 Sep; 14(18):6189-96. PubMed ID: 16782349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody catalysis via strategic use of haptenic charge.
    Kikuchi K; Hilvert D
    Acta Chem Scand (Cph); 1996 Apr; 50(4):333-6. PubMed ID: 8639376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tech.Sight. Antibody design by man and nature.
    Wentworth P
    Science; 2002 Jun; 296(5576):2247-9. PubMed ID: 12077422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Catalytic antibodies or "abzymes"].
    Lacroix-Desmazes S; Bayry J; Kazatchkine MD; Kaveri SV
    Med Sci (Paris); 2003 May; 19(5):519-22. PubMed ID: 12836378
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of hapten binding and catalytic determinants in a family of catalytic antibodies.
    Ulrich HD; Schultz PG
    J Mol Biol; 1998 Jan; 275(1):95-111. PubMed ID: 9451442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis for antibody catalysis of a cationic cyclization reaction.
    Zhu X; Heine A; Monnat F; Houk KN; Janda KD; Wilson IA
    J Mol Biol; 2003 May; 329(1):69-83. PubMed ID: 12742019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catalytic antibodies: evolution of protein function in real time.
    Lerner RA; Janda KD
    EXS; 1995; 73():121-38. PubMed ID: 7579971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Large rate accelerations in antibody catalysis by strategic use of haptenic charge.
    Thorn SN; Daniels RG; Auditor MT; Hilvert D
    Nature; 1995 Jan; 373(6511):228-30. PubMed ID: 7816136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A bait and switch hapten strategy generates catalytic antibodies for phosphodiester hydrolysis.
    Wentworth P; Liu Y; Wentworth AD; Fan P; Foley MJ; Janda KD
    Proc Natl Acad Sci U S A; 1998 May; 95(11):5971-5. PubMed ID: 9600901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.